Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « serum »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
serous < serum < setting  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000019 (2020) Martin Michaud [France] ; Florian Catros [France] ; Francis Gaches [France]Usefulness of serum amyloid a protein dosage for monitoring patients receiving tocilizumab.
000300 (2020) Abdur Rahman Rubel [Brunei] ; Pui Lin Chong [Brunei] ; Muhammad Syafiq Abdullah [Brunei] ; Rosmonaliza Asli [Brunei] ; Riamiza Natalie Momin [Brunei] ; Babu Ivan Mani [Brunei] ; Vui Heng Chong [Brunei]Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment.
000482 (2020) Hitoshi Irabu [Japon] ; Masaki Shimizu [Japon] ; Shuya Kaneko [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
000497 (2020) Satoshi Tsukuda [Japon] ; Tsukasa Ikeura [Japon] ; Takashi Ito [Japon] ; Koh Nakamaru [Japon] ; Masataka Masuda [Japon] ; Yuichi Hori [Japon] ; Manami Ikemune [Japon] ; Masato Yanagawa [Japon] ; Toshihiro Tanaka [Japon] ; Takashi Tomiyama [Japon] ; Takashi Yamaguchi [Japon] ; Yugo Ando [Japon] ; Kazushige Uchida [Japon] ; Toshiro Fukui [Japon] ; Akiyoshi Nishio [Japon] ; Rika Terasawa [Japon] ; Noboru Tanigawa [Japon] ; Kazuichi Okazaki [Japon]Clinical implications of elevated serum interleukin-6 in IgG4-related disease
000505 (2020) Giulia Lanzolla [Italie] ; Guia Vannucchi [Italie] ; Ilaria Ionni [Italie] ; Irene Campi [Italie] ; Federica Sileo [Italie] ; Elisa Lazzaroni [Italie] ; Michele Marin [Italie]Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
000626 (2013) H. M. Al Attia [Émirats arabes unis] ; M. A. Ibrahim [Émirats arabes unis]THU0388 Tocilizumab strongly suppresses the serum amyloid a level in refractory adult – onset still’s disease associated amyloidosis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "serum" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "serum" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    serum
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021